Salicylic Acid

Description

Salicylic acid is the active ingredient in this formulation, which is designed to relieve painful warts. The product is available in a package containing 18 medicated patches and 20 concealing pads, providing a comprehensive approach to wart treatment.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by a rough, 'cauliflower-like' appearance. Additionally, it provides relief from painful warts.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

After washing the affected area, the wart should be soaked for 5 minutes in comfortably warm water. Following this, the area must be dried thoroughly. If necessary, the medicated patch may be cut to fit the wart appropriately. The adhesive side of the patch should then be applied directly onto the wart. To ensure the area is concealed, the patch should be covered with a pad.

This procedure should be repeated every 48 hours as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in patients with diabetes or poor blood circulation, except when prescribed and monitored by a qualified healthcare professional, such as a doctor or podiatrist. This restriction is due to the potential for exacerbating complications associated with these conditions.

Warnings and Precautions

This product is intended for external use only. It is contraindicated for individuals with diabetes or poor blood circulation unless used under the guidance and supervision of a qualified healthcare professional, such as a doctor or podiatrist.

Application of this product is not recommended on the following areas: irritated, infected, or reddened skin; moles, birthmarks, and warts with hair growing from them; genital warts; warts on the face; and mucous membranes.

To ensure safety, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Should discomfort persist after application, it is essential for the patient to consult with their doctor or podiatrist for further evaluation and management.

Side Effects

Patients using this product should be aware that it is for external use only. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist.

The product should not be applied to irritated, infected, or reddened skin, nor should it be used on moles, birthmarks, or warts with hair growing from them. Additionally, it is not recommended for use on genital warts, warts on the face, or mucous membranes.

Patients are advised to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

If discomfort persists after application, patients should consult their doctor or podiatrist for further evaluation and management.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the potential for altered pharmacokinetics and pharmacodynamics in this population.

Pregnancy

There is no specific information regarding the use of Salicylic Acid wart remover plaster in pregnant patients. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for use during pregnancy. Therefore, healthcare professionals should exercise caution when considering the use of this product in pregnant women, as the potential risks and effects on fetal outcomes are not well characterized. It is advisable to weigh the benefits against any unknown risks before recommending this treatment to women of childbearing potential.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants have not been established. It is advisable to weigh the potential benefits against any unknown risks when considering treatment options for lactating patients.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution when prescribing to patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event that the product is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this product is not recommended for use in individuals with diabetes or poor blood circulation unless specifically directed and supervised by a healthcare professional, such as a doctor or podiatrist.

Additionally, healthcare providers should counsel patients to monitor their symptoms and to consult their doctor or podiatrist if discomfort persists after using the product. This ensures that any underlying issues can be addressed appropriately.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within a temperature range of 59°F to 86°F (15°C to 30°C) to maintain its integrity and efficacy. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable environment to prevent degradation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)